![](https://tracker.live.rns-distribution.com/track.live-rns/4246952_75d1671758db0ed18eba2dbba83793b2.png)
Spectra Systems Corporation
("Spectra" or the "Company")
Exercise of Options
Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, announces the exercise of options by an employee of Spectra.
The employee has exercised options over 20,000 shares of common stock of $0.01 each in the Company ("Shares") with an exercise price of 25p per share. The employee has elected to utilize the net cashless exercise feature and has therefore surrendered 3,205 shares to the Company. Accordingly the employee will be issued 16,795 shares of the Company.
The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.
Accordingly the Company has issued and will apply for 16,795 Shares to be admitted to trading on AIM, which is expected to take place on or around 26 January 2022 ("Admission").
Following Admission the Company's issued share capital will comprise:
· 1,061,682 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and
· 44,258,757 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).
In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission is 45,320,439 shares with voting rights attached (one vote per share). There are no shares held in treasury, therefore this figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Spectra under the DTRs.
Enquiries:
Spectra Systems Corporation Dr. Nabil Lawandy, Chief Executive Officer
| Tel: +1 (0)401 274 4700
|
WH Ireland Limited (Nominated Adviser and Broker) Chris Fielding (Managing Director, Corporate Finance)
Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate Finance) Amrit Nahal (Sales and Corporate Broking)
| Tel: +44 (0)207 220 1650
Tel: +44 (0)20 3328 5665
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.